André J. Müller
Direktor/Vorstandsmitglied bei Anokion SA
Profil
André J.
Müller was the founder of Actelion Ltd.
(1999) where he held the title of Vice Chairman in 2009.
Mr. Müller is also the founder of REFERENCE CAPITAL SA. Currently, he is a Director at Anokion SA. Previously, he held the position of Chairman at Addex Therapeutics Ltd.
(2002-2014) and ABIONYX Pharma SA. He was also a Director at Synthes, Inc., Kanyos Bio, Inc., and Chief Financial Officer at Biogen, Inc. Mr. Müller received an MBA from INSEAD and an undergraduate degree from the University of Geneva.
Aktive Positionen von André J. Müller
Unternehmen | Position | Beginn |
---|---|---|
Anokion SA
Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von André J. Müller
Unternehmen | Position | Ende |
---|---|---|
ADDEX THERAPEUTICS LTD | Vorsitzender | 27.06.2014 |
ACTELION | Gründer | 01.04.2009 |
Kanyos Bio, Inc.
Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | - |
REFERENCE CAPITAL SA
REFERENCE CAPITAL SA Investment ManagersFinance Genevest Consulting Group SA is an independent Swiss venture capital firm which was founded in 1983 to provide advisory services to institutional investors and high-net worth individuals. Based in Geneva, Genevest operates in close cooperation with Endeavour Vision SA. | Gründer | - |
Synthes, Inc.
Synthes, Inc. Medical SpecialtiesHealth Technology Synthes, Inc. engages in the development, production, and marketing of instruments, implants, as well as biomaterials for surgical fixation, correction, and regeneration of the human skeleton and its soft tissues. The company was founded in 1999 and is headquartered in Solothurn, Switzerland. | Direktor/Vorstandsmitglied | - |
Ausbildung von André J. Müller
INSEAD | Masters Business Admin |
University of Geneva | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
ADDEX THERAPEUTICS LTD | Health Technology |
ABIONYX PHARMA | Health Technology |
BIOGEN INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
Synthes, Inc.
Synthes, Inc. Medical SpecialtiesHealth Technology Synthes, Inc. engages in the development, production, and marketing of instruments, implants, as well as biomaterials for surgical fixation, correction, and regeneration of the human skeleton and its soft tissues. The company was founded in 1999 and is headquartered in Solothurn, Switzerland. | Health Technology |
Actelion Ltd.
Actelion Ltd. Pharmaceuticals: MajorHealth Technology Actelion Ltd. develops, produces and markets pharmaceutical drugs. The firm engages in research, development, manufacturing, and distribution of pharmaceutical, biological, and diagnostic products. The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann on December 30, 1999 and is headquartered in Allschwil, Switzerland. | Health Technology |
REFERENCE CAPITAL SA
REFERENCE CAPITAL SA Investment ManagersFinance Genevest Consulting Group SA is an independent Swiss venture capital firm which was founded in 1983 to provide advisory services to institutional investors and high-net worth individuals. Based in Geneva, Genevest operates in close cooperation with Endeavour Vision SA. | Finance |
Anokion SA
Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Health Services |
Kanyos Bio, Inc.
Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA. | Health Technology |